Simba Gill - 12 Sep 2022 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role: Director
Signature: /s /Allan Reine, M.D., Attorney-in-Fact
Issuer symbol: FHTX
Transactions as of: 12 Sep 2022
Net transactions value: +$59,860
Form type: 4
Filing time: 14 Sep 2022, 20:59:49 UTC
Previous filing: 22 Jun 2022
Next filing: 09 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FHTX	Common Stock	Options Exercise	$59,860	+82,000		$0.7300^*	82,000	12 Sep 2022	Direct
transaction	FHTX	Common Stock	Gift	$0	-47,939	-58%	$0.000000	34,061	13 Sep 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FHTX	Stock Options (Right to buy)	Options Exercise	$0	-82,000	-43%	$0.000000	107,188	12 Sep 2022	Common Stock	82,000	$0.7300	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a bona fide gift of Common Stock to a non-profit educational institution.
F2	The option vested as to 25% of the underlying shares of common stock on July 25, 2018, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option was fully vested.